Lupus (SLE) trials in China

In China 163 Also abroad 354

163 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitation
Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
Where
Hefei
People
100
Run by
The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07679776
Early phase 1Taking people
MTS109 in Patients With Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 65 years
People
15
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT07526350
Phase 1Not yet taking people in China
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Where
Qingdao
Age
18 years to 70 years
People
18
Run by
The Affiliated Hospital of Qingdao University
See details and how to joinNCT07676266
Phase 1/2Taking people
A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
Where
Beijing
Age
18 years to 65 years
People
218
Run by
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
See details and how to joinNCT06535412
Early phase 1Taking people
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
Where
Nanjing
Age
18 years to 65 years
People
15
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06946485
Early phase 1Not yet taking people in China
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
Where
Hangzhou, Nanjing
Age
5 years to 20 years
People
30
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07674147
No phaseEnrolling by invitation
CHT105 for the Treatment of Refractory Lupus Nephritis
Where
Nanjing
Age
18 years to 65 years
People
14
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07517536
Phase 2/3Taking people
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
Where
Beijing
Age
18 years to 65 years
People
164
Run by
Chinese SLE Treatment And Research Group
See details and how to joinNCT07657793
Phase 1Taking people
NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
Where
Guangzhou
Age
18 years to 65 years
People
18
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06676631
Early phase 1Taking people
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
Where
Beijing
Age
18 years to 60 years
People
5
Run by
Circunited BioPharma (Shenzhen) Co., Ltd.
See details and how to joinNCT07629596
Early phase 1Taking people
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
Where
Shanghai
Age
18 years to 70 years
People
18
Run by
RenJi Hospital
See details and how to joinNCT05858684
Early phase 1Taking people
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
Where
Beijing
Age
18 years to 75 years
People
18
Run by
Peking University People's Hospital
See details and how to joinNCT07617740
No phaseNot yet taking people in China
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
Where
Beijing
Age
18 years to 75 years
People
75
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07593911
Phase 3Taking people
A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus
Where
Beijing
Age
18 years to 80 years
People
316
Run by
Beijing Mabworks Biotech Co., Ltd.
See details and how to joinNCT07405970
No phaseTaking people
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
Where
Nanjing
Age
18 years to 70 years
People
72
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558850
No phaseTaking people
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Where
Shanghai
Age
7 years to 17 years
People
60
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07425730
Phase 2Taking people
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
Where
Linfen
Age
18 years to 70 years
People
120
Run by
InventisBio Co., Ltd
See details and how to joinNCT07311200
Early phase 1Not yet taking people in China
Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
Where
Xi'an
Age
18 years to 65 years
People
15
Run by
Air Force Military Medical University, China
See details and how to joinNCT07535138
Early phase 1Taking people
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
Where
Deyang
Age
18 years to 65 years
People
6
Run by
CytoCares Inc
See details and how to joinNCT07193810
Phase 1/2Taking people
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
Where
Shenzhen
Age
18 years to 70 years
People
24
Run by
Beijing Biotech
See details and how to joinNCT07523542
Phase 1Not yet taking people in China
Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus
Where
Wuhan
Age
18 years to 75 years
People
30
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07512947
Early phase 1Taking people
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
Where
Hangzhou
Age
5 years and over
People
36
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07490041
No phaseTaking people
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Where
Wuhan
Age
18 years to 70 years
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470151
Phase 2Taking people
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Where
Nanjing
Age
14 years to 65 years
People
50
Run by
Nanjing University School of Medicine
See details and how to joinNCT07340463
Phase 1/2Taking people
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
Where
Beijing
Age
3 years to 65 years
People
18
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06585514